This content is from: Video Actavis's Brent Saunders Is Pharma's Best-Looking CEO Content Editor Anne Szustek spoke with Saunders about the Actavis-Allergan merger, innovation and a new segment in the industry: growth pharma. By Editors March 12, 2015
This content is from: Portfolio Actavis CEO Brent Saunders Has a Vision for Growth Once Actavis completes its merger with Allergan, CEO Brenton Saunders will need to focus on getting the two companies’ cultures and strategies on the same page. By Anne Szustek March 12, 2015
This content is from: Portfolio Deals of the Year 2014: Actavis Realizes Bigger Pharma Ambitions For CEO Brenton Saunders, the $66 billion friendly takeover of Allergan is just the latest in a string of health care mergers. By Anne Szustek December 10, 2014
This content is from: Premium Tiger Bloc’s Biggest Holdings: Actavis, CDK and JD.com Group of 50 Tiger Cubs, Seeds and Grandcubs often invest in many of the same stocks. The big winner: Irish drugmaker Actavis. By Stephen Taub June 04, 2015
This content is from: Portfolio The Morning Brief: Allergan Talks With Actavis Threaten Valeant, Pershing Bid By Stephen Taub November 13, 2014
This content is from: Portfolio The Morning Brief: Ackman’s Pershing Square Wins Big on Actavis-Allergan Deal By Stephen Taub November 18, 2014
